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Abstract 
Bioactive glasses are going to play an essential role in the manufacture of 3D scaffolds 
for bone tissue engineering. Mimicking natural bone, synthetic scaffolds must be 
tailored at a hierarchy of scales. First, the glasses composition must be carefully 
designed at the atomic–molecular level to ensure bioactivity and beneficial effects 
including capabilities for enhance osteogenesis and vascularization or to exert 
bactericide action. Moreover, the glasses structure need to be designed at the nanometric 
scale. With this purpose, mesoporous bioactive glasses, exhibiting ordered 
arrangements of nanometric pores, are optimum candidates. The microstructure of 
glasses must also be designed to achieve suitable interactions with living cells. Finally, 
the scaffolds obtained with bioactive glasses must display interconnected pores over 
100 µm to made possible bone cell ingrowths and angiogenesis. In this article, the 
advances in the field of bioactive glasses through the control of the chemical, nanometer 
scale, microstructural properties and architectural features are presented and discussed. 
A detailed control of these four levels of matter organization will allow optimizing the 
biological response of bioactive glasses when used in bone tissue regeneration.  
Keywords: Bioactive glasses, bone tissue engineering, composition, mesostructure, 
microstructure, macrostructure.  
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Introduction 
The discovering of bioactive glasses at the end of the 1960s meant one of the most 
important achievements in the field of bioceramics [1]. Prof. Larry L. Hench wrote a 
brilliant page in the History of Biomaterials, when he revealed the capability of certain 
SiO2 based glasses to bond to the bone through a chemically stable and mechanically 
strong linkage. Since then, the development and clinical applications of bioactive 
glasses have growth during the last 45 years. These glasses have a composition based on 
SiO2-P2O5-Na2O-CaO, where SiO2 and P2O5 are network formers, whereas CaO and 
Na2O are network modifiers and play a fundamental role in the bioactive behavior of 
this material [2,3]. We can say that Prof. Hench evidenced the bone regeneration 
capability of silica based compounds by controlling the chemical composition, i.e. by 
tailoring the matter at the atomic scale. Thereafter the incorporation of the sol-gel 
chemistry [4] to the preparation of bioceramics resulted in new bioactive glasses, 
usually called sol-gel glasses (SGGs), which exhibited a very high potential to develop 
better implants with osteogenic capabilities. This potential is supported by the enhanced 
textural properties inherent to the sol-gel method, i.e. surface area, porosity and other 
microstructural features respect to the conventional melt derived bioglasses (MDGs) 
[5].  
Recently, a new generation of mesoporous bioactive glasses (MBGs) has been 
developed [6]. MBGs are the result of tailoring bioactive glasses at the nanometer scale 
through the incorporation of structure directing agents to the sol-gel synthesis. The 
result is the preparation of highly ordered mesoporous materials with surface and 
porosity up to three times higher than obtained for the conventional sol-gel bioglasses 
[7]. MBGs exhibit the fastest in vitro bioactivity observed up to date. However, the real 
clinical significance is still unknown, as the ordered mesoporous structure could allow 
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incorporating osteogenic agents, osteoclasts inhibitors, antitumoral drugs, etc. thus 
providing an excellent potential for the treatment of bone diseases [8].  
Finally, the regeneration of critical bone defects is one of the most challenging 
and difficult issue to be tackled by biomaterials science. The regeneration in critical 
defects requires pieces that must fit to the defect size and morphology. Moreover, the 
implants must have pores large enough to let the bone cells colonization and blood 
vessels formation [9]. In this sense, rapid prototyping techniques and additive 
preparation methods allow the control of the implants macro-architecture and are called 
to play a very important role in regenerative therapies [10].  
Herein, we review and discuss the advances in the field of bioactive glasses 
through the control of the chemical, nanometer scale, microstructural properties and 
architectural features (Figure 1). Through the control of these four levels of matter 
organization, bioactive glasses can optimize their response in the essential biological 
features involved in the bone regeneration processes. 
2.- Design of the composition of bioactive glasses 
The three basic components of bioactive glasses are SiO2, CaO and P2O5. The 
maximum content SiO2 for a positive bioactive response is 60 mol-% in MDGs and 90 
mol-% in SGGs and MBGs. CaO, is also essential and greatly influences the porosity in 
SGGs and MBGs. P2O5 is not essential but beneficial when present in relatively low 
concentrations [11].  Si, Ca and P participate also in angiogenesis and bone tissue 
growth.  
First attempts to improve Hench´s Bioglass
®
 tried to increase its bioactivity and 
mechanical properties by modifying its composition. However, substitutions of MgO or 
CaF2 for CaO and of K2O for Na2O did not altered significantly the bone bonding 
behavior. Moreover, Al2O3, in contrast with B2O3, inhibited bone bonding [12]. On the 
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other hand, mechanical properties of glasses were substantially improved only when 
glass-ceramics or composites were synthesized. 
In the last few decades, numerous oxides were included in the three families of 
bioactive glasses looking for favorable biological action when used in bone tissue 
engineering (BTE) application [13]. That way, Zn, Sr, Cu and Co oxides additions 
provoked stimulatory effects in osteogenesis and angiogenesis, whereas Ag, Cu or Zn 
oxides conferred to glasses antimicrobial or anti-inflammatory therapeutic effects [14]. 
The additions of other elements such as Li, Ce and Ga were also investigated. Thus, a 
Li-doped MBG has promoted regeneration of osteochondral defects through the release 
of Li
+
 ions [15]. On the other hand, Ce or Ga additions were investigated because Ce
3+ 
favors the osteoblasts growth and reduced enamel mineralization, while Ga
3+ 
increases 
the calcium content in bone and block bone resorption [16,17]. 
Figure 2 shows the numerous ions investigated to induce beneficial biological 
properties in bioactive glasses designed for BTE, including osteogenesis, angiogenesis 
or antibacterial capacity [8]. As it is observed the main role of these elements is to 
induce osteogenesis. For instance, the release from glasses of Sr
2+
, Zn
2+
, Mg
2+
 or Cu
2+
 
ions stimulated the osteogenic differentiation of bone marrow stromal cells and 
periodontal ligament cells. Furthermore, Sr
2+
 stimulated alkaline phosphatase activity 
and osteogenic-related gene expression of periodontal ligament cells. Boron, released as 
BO3
3-
, enhanced the osteoblasts proliferation. Regarding iron oxide, it was initially 
included to obtain magnetic scaffolds for hyperthermia treatment, but Fe
3+ 
ions release 
significantly improved the mitochondrial activity and gene expression of bone marrow 
stromal cells. Finally, the inclusion of tetravalent Zr
4+
 favored osteoblasts proliferation 
and differentiation because the decrease of the resorption rate of the glass scaffold.  
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 Besides osteogenesis, a bioactive glass designed for BTE needs to stimulate the 
angiogenesis necessary for the living tissue formation. Actually, a poor vascularization 
at the injury site is one of the most important concerns in BTE. As is observed in Figure 
2, only Cu
2+
 and Co
2+
 ions were investigated with this purpose. The reason is that they 
induce significant hypoxia (low oxygen pressure) that drives angiogenesis because 
hypoxic conditions initiate the expression of genes associated with living tissue 
regeneration (including bone). In this regards, it must be considered that although both 
ions induce hypoxia in stem cells, the potential toxicity of Co
2+
 is higher than Cu
2+
. 
On the other hand, glasses designed for BTE must exhibit antibacterial 
capabilities. It must be considered that post-operative bacterial infection is one of the 
major issues associated with the treatment of bone fractures and diseases with implants. 
In this regards, the release of Ag
+
, Cu
2+
, Zn
2+
 and Ga
3+
 showed antibacterial activity 
against Staphylococcus Aureus and Escherichia Coli [18].  
In this point is necessary to contemplate that in the design of a bioactive glass 
intended to exhibit antimicrobial, ostoegenic, angiogenic features or others, is essential 
to know the amount of ions released from glass to medium and check if this value is 
inside the therapeutic range and out of ineffective and toxic levels. For instance, in an 
unpublished study of the authors, a MBG containing 3.5 mol-% of Ga2O3 did not 
exhibit antibacterial properties, because Ga
3+
 ions remained in the glass without be 
released to medium. In another study, a MBG containing 7 mol-% of ZnO exhibited 
antibacterial properties, but the amount of Zn
2+
 ions released was so high that converted 
the glass in non-biocompatible in a cell osteoblasts culture [18].  In such study, the 
upper limit of ZnO in the MBG to exhibit both biocompatibility and antimicrobial 
capability was established at 4 mol-%.  
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Finally, Zn, Ca, or Ce were included in bioactive glasses designed for other 
applications such as in nerve guidance conduits. Zn and Ca because they are involved in 
peripheral nerve regeneration and Ce because is a neuroprotective agent. Moreover, the 
inclusion of Y is investigated for glasses designed for radionuclide therapy.   
3.- Mesoporosity design of bioactive glasses 
MDGs glasses are dense materials. Thus, their textural properties are negligible. 
However, SGGs and MBGs exhibit high surface area and porosity. Both families of 
glasses present cylindrical pores with diameters between 2 and 10 nm, i.e. mesopores, 
open at both ends, but only MBGs exhibit ordered mesopores arrangements. The design 
of the bioactive glasses structure at nanometric level can bring enhanced bioactivity and 
the possibility to load glasses with biomolecules able to drive the living tissues 
regeneration. In SGGs, the mesopore size and volume can be designed by controlling 
the synthesis parameters including temperature of thermal treatments and the glass 
composition, particularly the CaO content [19].  
To understand how it is possible to design the MBGs nanostructure it is 
necessary to know the method of synthesis. Due to MBGs are CaO-containing 
multicomponent systems, they need to be synthesized by evaporation induced self-
assembly method (EISA) [20]. As structure directing agent, a non-ionic surfactant such 
as Pluronic
®
 123 is used. A diluted solution of surfactant and precursors is prepared in 
ethanol/water. The evaporation allows reaching the critical micellar concentration of 
surfactant when the self-assembly silica-surfactant micelles and further organization 
into liquid crystalline mesophase take place. After the surfactant removal, MBGs are 
obtained. This method allows designing textural and structural characteristics that 
control the bioactive response of MBGs. Ordered mesoporous arrangement depends on 
type and concentration of surfactant, solvent, additives, pH, temperature but the critical 
Page 7 of 27 International Journal of Applied Glass Science
For Review Only
8 
 
parameters are calcium and phosphorous contents and solvent evaporation temperature 
[21,22].  
CaO modifies the mesoporosity of the amorphous silica walls and the mesopore 
structure. Thus, varying the CaO content, 3D-cubic (Ia-3d, space group) or 2D 
hexagonal (p6mm, plane group) mesopores arrangements can be obtained. These 
modifications can be explained considering that Ca
2+
 decrease the network connectivity. 
Consequently, the inorganic/organic volume ratio of micelles increases with the Ca
2+
 
content, decreasing the curvature of surfactant micelles and contributing to the 
formation of hexagonal phases. However, low CaO contents yields to cubic phases. In 
addition, the textural features of MBGs are ruled by the porosity coming from the 
surfactant removal, at difference with SGGs where mainly depend on the CaO content.   
P2O5 content is also critical in mesoporous structure and bioactive behavior of 
MBGs. The presence of P produced a 3D-cubic structure, while its absence yields to 
2D-hexagonal structure. It was demonstrated that P2O5 bind to CaO forming amorphous 
calcium phosphate clusters at the glass surface. Thus, Ca
2+
 is retired from the glass 
silica network and the effect to include P2O5 in MBGs is analogous to decrease the CaO 
content i.e. to form the cubic structure. Thus, in P-free MBGs hexagonal phases were 
formed. However, textural parameters in MBGs do not experienced significant changes 
because of the presence or absence of phosphorus confirming that such main parameters 
are governed by surfactant removal not being affected by the compositional variations. 
Evaporation temperature in the EISA synthesis is also an effective parameter to 
control the MBGs mesostructure. For identical MBG composition, the structure can 
change from 3D-cubic to 2D-hexagonal by decreasing the solvent evaporation 
temperature. Indeed, both structures can coexist for intermediate temperatures. When 
temperature increases, the micelle size increases by reduced hydrogen interaction 
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between micelles and water which favor the 3D-cubic structure. However, 2D-
hexagonal structure is formed at low evaporation temperatures.  
Textural parameters (surface area and porosity) of MBGs are approximately 
twice than SGGs with similar composition. Thus, for traditional SGGs the typical 
surface area values obtained by the Brunauer Emmett and Teller method (SBET) are 
between 100 and 250 m
2
/g and the pore volume (VP) in the 0.2 – 0.4 g/cm
3 
interval. On 
the other hand, for MBGs, typical SBET values are from 200 to 500 m
2
/g and VP usually 
ranges between 0.5 – 0.7 g/cm
3
. Figure 3 shows that MBGs exhibit textural properties 
intermediate between SGGs and silica mesoporous materials, which often reach and 
even exceed 1000 m
2
/g of SBET and 1 cm
3
/g of VP. However, MBGs exhibit the quickest 
in vitro bioactive response of all the synthetic materials reported [23,24].   
 
High Resolution Transmission Electron Microscopy (HRTEM) images included 
in Figure 3 shows that SGGs and MBGs are materials with textural properties 
intermediate between SGGs and mesoporous materials. Indeed the structure of both 
families of glasses is identic at the atomic scale but differs at the mesoscale. As 
expected, because they are glasses, high magnification HRTEM images of the SSG and 
the MBG do not show order. Accordingly, the Electron Diffraction (ED) patterns 
included as insets are typical of materials exhibiting an amorphous structure at atomic 
scale. 
 However, in the HRTEM image of the MBG at lower magnification, mesopores 
arrangement is clearly visualized and the ED pattern confirms the hexagonal 
arrangement at the mesoscale. Therefore, although the three families of bioactive 
glasses exhibit the amorphous structure at atomic scale, MBGs exhibit also mesopores 
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arrangement, which confers them outstanding properties that make them optimum 
candidates as raw materials to fabricate scaffolds for tissue engineering applications.  
 
4. Microstructural design of bioactive glasses 
Tailoring the bioactive glasses at the micrometrical scale involves controlling 
the particle size and morphology, as well as the inter-granular porosity when the 
implant is a solid piece. It is well known that in the range between 1 – 1000 
micrometers, the microstructural characteristics condition different processes that take 
place at the implant-tissue interface. In this way, micro-features (particle size and 
porosity) about 1 µm determine, among other factors, the newly formed carbonate 
hydroxyapatite growth onto the surface [25] and the serum proteins adhesion [26]. 
Besides, those micro-features in the range of 1 – 20 µm are related with the processes of 
cellular adhesion and proliferation. 
Most of the clinical applications of bioactive glasses require their implantation 
as granulates [27], as this form increases the surface contact between the bone and the 
graft. Depending on the application method and the anatomical location the particle size 
varies. For instance, the bioactive glass particles incorporated within toothpastes for 
dentine regeneration in the treatment of tooth hypersensitivity and commercialized as 
NovaMin
®
 (GlaxoSmithKline LLC, Wilmington, NC), exhibit particle sizes of about 20 
µm. In this case, the friction during brushing favors the adhesion to dentine, blocking 
the dentinal tubules and relieving the pain. The ions released by the glass trigger the 
apatite growth that occludes the tubules until the permanent filling of the cavities takes 
place. The small particles size facilitates their crossing through the enamel and avoids 
the user to feel them. 
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 In the case of periodontal and orthopedic applications, the bioglass derived 
products are manufactured with larger particle sizes [28]. This microstructural changes 
are addressed to match the bone growth with the glass dissolution while fitting with the 
anatomical volume conditions. In this sense PerioGlas (Novabone Products LLC) is a 
particulate material for periodontal tissue repair made of particles in the range of 90 – 
710 µm. Other commercial products aimed for similar applications are Biogran (Gobal 
Headquarters, FL) with a particle size distribution ranging in size between 300 – 360 
µm. In the case of bioactive glasses manufactured for spinal grafting, the particle sizes 
found fall in the range of 1 – 2 mm (BonAlive, BoneAlive Biomaterials Ltd., Turku, 
Finland) 
 The ionic dissolution products of bioactive glasses lead to other beneficial 
effects such as osteoinductive behavior and antimicrobial properties. Some studies point 
out that Bioglass particulates smaller than 100 µm show antimicrobial and 
antiinflamatory effects [29-32], although the mechanism that explain these properties 
are still unknown. However, the microstructure determines the kinetic release of the 
ionic products, which strongly affects this col-lateral behavior. In this sense, Cerruti et 
al [33] could establish differences by dissolving Bioglass particles of 2, 16 and 90 µm in 
Tris-Buffer. The smallest particles released the network modifiers cations (Ca
2+
 and 
Na
+
) faster, thus leading to a higher pH increase of the surrounding fluid. Besides, the 
newly formed apatite layer was also thinner compared with that precipitated onto the 
largest particles. The silica released, presumably as silicic acid, was not affected by the 
particle size. 
 Not only the particle size control but also the particle morphology has awakened 
much interest for designing the microstructure of bioactive glasses. The versatility of 
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the sol-gel method allows obtaining a variety of morphologies through the addition of 
different catalysts (Figure 4). In this sense, Chen et al [34] achieved to control the 
morphology of SiO2-CaO-P2O5 sol-gel bioactive glasses using lactic acid (LA) as 
catalyst of the TEOS and TEP hydrolysis and, subsequently, adding ammonia to carry 
out the gelling under basic conditions. The particle morphology changed as a function 
of the LA/TEOS ratio and the different textures obtained resulted in different in vitro 
bioactive behavior: those morphologies containing nanoparticles and narrow mono or 
bi-modal pore size distributions exhibited faster formation of an apatite-like layer in 
contact with simulated body fluid (SBF). 
 The preparation of spherical particles is a topic of maximum interest in the field 
of the microstructural design of bioactive glasses. Certain studies claim that spherical 
particles exhibits better physic-chemical and biological behavior than bulky irregular 
bioglass particles. [35,36] Although some interesting results have been obtained in vitro 
with human marrow mesenchymal stem cells [37,38], up to date there are no in vivo 
evidences supporting this claim. However, the spherical morphology is optimal to tailor 
drug delivery matrixes made of mesoporous bioactive glasses. The dimensions of the 
carrier, the volume/surface ratio and, therefore, the kinetic of drug release can be easily 
tailored if the carriers are spherical and mono-dispersed particles instead of irregular 
bulky poly-dispersed grains. The synthesis of SiO2 based mesoporous spherical 
nanoparticles is commonly carried out through the modified Stöber method.[39] This 
method basically consists on the precipitation of depolymerized silica in basic media in 
the presence of a cationic surfactant. The highly negative charge concentrated at the 
SiO2 surface under basic conditions force nanoparticles to grow spherically, thus 
reducing the surface energy. In the case of calcium containing bioactive glasses, several 
research groups devoted with the obtaining of mesoporous bioactive spheres have 
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developed different strategies to achieve this aim. For instance, Hu et al [40] achieve to 
prepare monodispersed mesoporous bioactive spheres in the system SiO2-CaO-P2O5 by 
means of adding dodecylamine (DDA) as basic catalyst and structure directing agent. 
DDA is an amphyfilic molecule that templates the mesoporosity while catalyzes the 
hydrolysis and condensation under basic media, thus leading to spherical morphology as 
explained above. 
 The alkaline precipitation method allows the synthesis of mesoporous bioactive 
spheres in the submicron scale. However, the nanospheres prepared by this route have 
been prepared with calcium contents below 20% mol or less [38,41]. The main 
drawback of the alkaline precipitation is the precipitation of calcium hydroxide if the 
Ca
2+
 concentration is too high. The precipitation as a solid phase impedes the 
incorporation of Ca
2+
 as network modifier within the silica matrix. For this reason, 
porous spherical particles with high calcium content have been prepared through 
confined spaces synthesis methods, such as microemulsions, aerosol assisted methods 
[42] or with templates that impose spherical morphology such as chitosan microspheres 
[43]. In these cases the alkaline environment is not needed to form spheres and the acid 
pH allows higher calcium contents in the reaction media.  
5. Macro-architectural design of bioactive glasses. 
Manufacturing scaffolds able to stimulate bone regeneration is one of the most 
exciting challenges in the field of bioactive glasses. Bioactive glasses can be 
manufactured as 3D macroporous bone grafts that provide a temporary structural 
support during the bone tissue ingrowth. Eventually, the scaffolds are intended to be 
resorbed thus achieving the restitutio ad integrum of the damaged bone. For this 
purpose, the ideal bone graft has been described as that able to [10]: 
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a) Be compatible and reabsorbible while showing a degradation rate that match 
with the bone tissue ingrowth, thus keeping the mechanical stability during the 
healing process. 
b) Show an appropriated surface for the adhesion, differentiation and proliferation 
of osteoprogenitor cells  
c) Exhibit a three dimensional and highly porous network to allow the newly 
formed bone tissue all through the graft. In addition, this macroporous 
arrangement should promote the angiogenesis, nutrients transport and metabolic 
wastes rinsing. 
d)  Exhibit mechanical properties similar to those of the host tissue (commonly 
cancelous bone) 
e) Show a manufacturing process scalable to the industrial level  
 There are many different strategies aimed to prepare bioactive glass based 
scaffolds.[44-47]. Among them, foaming [48] and electrospinning [49] methods are 
some of the most important strategies used so far. The preparation of bioactive glass 
macroporous scaffolds through foaming processes have been widely studied and 
optimized. The method consists of the preparation of the bioactive glass by the sol-gel 
method adding a surfactant during the sol stage. By means of vigorous stirring a gas 
phase (atmospheric air) is interposed within the sol, which remains stable for short time 
before collapsing. The size and amount of the air bubbles determine the final 
macroporosity, so that is important to accelerate the gelation for keeping the porosity of 
the foam. For this purpose HF is incorporated as catalyzer achieving the gelation stage 
after a few minutes due to the complexation between fluoride and silica. After the 
calcination treatment, surfactant and nitrates are removed. In this way, scaffolds 
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exclusively made of bioactive glass are obtained, showing mechanical properties similar 
to those of cancellous bone. 
Electrostatic spinning or electrospinning is an interesting method for producing 
nonwoven fibers with diameters in the range of submicrometers down to nanometers. In 
this process, a continuous filament is drawn from a polymer solution or melts through a 
spinneret by high electrostatic forces and later deposited on a grounded conductive 
collector [50]. This technique allows obtaining structures with high surface areas that 
somehow mimics the bone extracellular matrix. A first approximation is the preparation 
of composite scaffolds with electrospun polymer fibers and subsequent coating with a 
sol-gel bioactive glass. [51] However, other routes must be followed to obtain inorganic 
scaffolds prepared by electrospinning techniques. An interesting strategy has been 
recently developed with electrospun inorganic sol-gel solutions. This method results in 
3D bioactive scaffolds with cotton-wool like structures that exhibit flexible structures 
without the need for binders. [52] The preparation of MBGs scaffolds by 
electrospinning techniques have been recently carried out by different authors. The 
structures prepared of organic/inorganic composite fibers have shown very promising 
osteoregeneration properties both in vitro and in vivo [53,54], as well as very interesting 
capabilities to deliver different growth factor in a sequential manner. [55]     
 The development of rapid prototyping techniques and additive manufacturing 
methods has created enough technology to design customized implants that fulfill the 
morphological requirements of the defect. [56] Ideally, the implant morphology can be 
tailored from the defect medical imaging. Thereafter, the macroporous structure is built 
by means of any of the additives manufacturing techniques, which involve the 
fabrication of the object by building up in layers by depositing material, i.e. the 
bioactive glass. Yun et al [57] incorporated the free form fabrication of MBGs implants 
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through computer assisted designs for the preparation of MBGs macroporous scaffolds 
with ordered macroporous architecture. These scaffolds showed three different porous 
systems in the nanometer, micrometric and macroscopic levels. The structure directing 
agent supplied the ordered mesoporous arrangement at the nanometer level, the 
incorporated methylcellulose left pores of several microns after calcination and the layer 
by layer robocasting procedure built the macroporous architecture. 
 MBGs scaffolds have demonstrated to improve their mechanical properties 
during the bioactive process under in vitro conditions. [58] The fast formation of an 
apatite-like phase that reinforces the grain boundaries result in a significant increasing 
of compressive strength values.  However, even with this mechanical reinforcement, the 
mechanical properties of MBGs based scaffolds are still clearly insufficient for most of 
orthopedic applications or for bone regeneration purposes in critical defects. The 
combinations of MBGs with biocompatible polymers, such as polycaprolactone (PCL) 
[59], polyvinyl alcohol (PVA)[60], poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) 
(PHBHH) [61] etc., have been proposed. These composite scaffolds have shown 
excellent results regarding the mechanical improvement, while keeping their bioactive 
properties under both in vitro and in vivo conditions. In this sense, the development of 
macroporous scaffolds manufactured with MBGs, and combined with antiosteoporotic 
agents, opens very promising perspectives for the treatment of fractures in osteoporotic 
patients.[62] 
Conclusions 
Bioactive glasses are materials with optimum present and future in the design of 3D 
scaffolds for bone tissue engineering applications. With the appropriate design of 
composition, mesostructure, microstructure and macrostructure and, after decorate the 
scaffolds with signals and cells, optimum constructs for bone regeneration will be 
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obtained. Such constructs will exhibit the required features for this application including 
mechanical stability and resorption as well as osteogenesis, angiogenesis, cell adhesion 
and cell proliferation capabilities and good pathological response. 
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Figure Captions 
Figure 1. The four levels of matter organization at which the bioactive glasses must be 
designed and the essential biological features exerted for each level.  
Figure 2. Inorganic ions with its biological activity investigated to upgrade SiO2-CaO-
P2O5 bioactive glasses designed as scaffolds for bone BTE applications.   
Figure 3. HRTEM images and ED patterns of typical examples of a SGG, a MBG and a 
mesoporous material. Average values of textural properties and time required to be 
coated by an apatite layer after be soaked in SBF are also included.    
Figure 4. Different microstructures of MBGs particles prepared by different strategies. 
(a) Evaporation induced self-assembly (EISA) method. (b) Aerosol assisted EISA 
method. (c) Modified Stöber method. (d) Hydrothermal SBA-15 synthesis. 
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Figure 1. The four levels of matter organization at which the bioactive glasses must be designed and the 
essential biological features exerted for each level.  
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Figure 2. Inorganic ions with its biological activity investigated to upgrade SiO2-CaO-P2O5 bioactive glasses 
designed as scaffolds for bone BTE applications.  
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Figure 3. HRTEM images and ED patterns of typical examples of a SGG, a MBG and a mesoporous material. 
Average values of textural properties and time required to be coated by an apatite layer after be soaked in 
SBF are also included.    
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Figure 4. Different microstructures of MBGs particles prepared by different strategies. (a) Evaporation 
induced self-assembly (EISA) method. (b) Aerosol assisted EISA method. (c) Modified Stöber method. (d) 
Hydrothermal SBA-15 synthesis  
25x18mm (300 x 300 DPI)  
 
 
Page 27 of 27 International Journal of Applied Glass Science
